Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Data are from the most recent national surveys available in each country.
Some countries use a slightly different age range to the EMCDDA standard age range for young adults. Variations in age ranges may to a small extent account for disparities between countries.
Belgium: 2001; 15-24 y. n=
Denmark: 2000; 16-24 y. n=1754
Germany: 2003; 18-24 y. n=1891
Estonia: 2003; 15-24 y. n=329
Greece: 2004; 15-24 y. n=1785
Spain: 2001; 15-24 y. n=3368
Ireland: 2002/03; 15-24 y. n=
Italy: 2003; 15-24 y. n=2112
Cyprus: 2003; 15-24 y. n=420
Latvia: 2003; 15-24 y. n=
Hungary: 2003; 18-24 y. n=943
Netherlands: 2000/01; 15-24 y. n=
Poland: 2002; 16-24 y. n=
Portugal: 2001; 15-24 y. n=3099
Slovakia: 2002; 18-24 y. n=
Finland: 2002; 15-24 y. n=614
Sweden: 2004; 18-24 y. n=1171
UK (E&W): 2003/04; 16-24 y. n=5429
Norway: 1999; 15-24 y. n=
Sources:
Reitox national reports (2004), taken from population surveys, reports or scientific articles. See also [Table GPS-0] in the 2005 statistical bulletin.